Back to PathoKing

Coeliac disease module

Coeliac Disease

Understand coeliac disease as HLA-associated immune injury triggered by gluten, causing small-intestinal villous atrophy, malabsorption and intestinal and extra-intestinal manifestations.

intermediate35 min

Clinically reviewed by Mark · NMC-registered nurse

Aetiology

What enables coeliac disease?

Gluten is necessary, but HLA susceptibility and immune context determine disease.

Gluten exposure

Typical setting: Wheat, barley and rye ingestion.

Resistant gliadin-related peptides reach the small bowel and provide the antigenic driver; oats require contamination-aware specialist advice.

HLA-DQ2 or DQ8

Typical setting: Almost all affected people carry a permissive HLA molecule.

These molecules bind deamidated gluten peptides for T-cell presentation, but carriage is common and not sufficient for disease.

Family and autoimmune susceptibility

Typical setting: First-degree relatives, type 1 diabetes or autoimmune thyroid disease.

Shared HLA and immune-regulatory genetics increase prevalence and justify a lower threshold for testing.

Selective IgA deficiency

Typical setting: More common in coeliac disease than the general population.

It reflects shared immune susceptibility and makes standard IgA serology falsely negative unless total IgA is checked.

Environmental modifiers

Typical setting: Infections and microbiome or feeding factors have been studied.

They may alter mucosal permeability and tolerance, but no single infection or feeding practice is a sufficient proven cause.

Mechanism chain

Mechanism chain

Gluten peptides are modified, presented and converted into T-cell and epithelial injury.

1

Gluten peptides resist digestion

Proline-rich gliadin fragments persist in the lumen and cross the epithelial barrier.

2

tTG deamidates gliadin

Enzymatic modification gives peptides higher affinity for HLA-DQ2 or DQ8.

Checking account access...